Evidence map›Paper›PMID 42357540›Full record

ArticleMolecules (Basel, Switzerland)2026

Purification of Actinium-225 from Thorium via Selective Precipitation.

Steven J Schultz, Sara L Adelman, Guy H Dutech, Michael E Fassbender, Christopher D Henning, Brian N Long, Kristen A Pace, Stosh A Kozimor, Veronika Mocko, Thomas E Shaw

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Molecules (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Steven J SchultzLos Alamos National Laboratory (LANL), P.O. Box 1663, Los Alamos, NM 87545, USA.ORCID 0000-0002-9890-2648
Sara L AdelmanLos Alamos National Laboratory (LANL), P.O. Box 1663, Los Alamos, NM 87545, USA.ORCID 0000-0001-7989-3451
Guy H DutechLos Alamos National Laboratory (LANL), P.O. Box 1663, Los Alamos, NM 87545, USA.ORCID 0000-0003-4169-6369
Michael E FassbenderLos Alamos National Laboratory (LANL), P.O. Box 1663, Los Alamos, NM 87545, USA.ORCID 0000-0003-3784-0276
Christopher D HenningLos Alamos National Laboratory (LANL), P.O. Box 1663, Los Alamos, NM 87545, USA.
Brian N LongLos Alamos National Laboratory (LANL), P.O. Box 1663, Los Alamos, NM 87545, USA.ORCID 0000-0003-4410-4509
Kristen A PaceLos Alamos National Laboratory (LANL), P.O. Box 1663, Los Alamos, NM 87545, USA.ORCID 0000-0001-8574-8939
Stosh A KozimorLos Alamos National Laboratory (LANL), P.O. Box 1663, Los Alamos, NM 87545, USA.ORCID 0000-0001-7387-0507
Veronika MockoLos Alamos National Laboratory (LANL), P.O. Box 1663, Los Alamos, NM 87545, USA.ORCID 0000-0001-6041-6778
Thomas E ShawLos Alamos National Laboratory (LANL), P.O. Box 1663, Los Alamos, NM 87545, USA.ORCID 0000-0003-0080-2903

Funding

U.S. Department of Energy Isotope Program N/A
6 · The paper itself

Abstract

Numerous promising cancer treatments currently in clinical trials rely on the production and purification of actinium-225 (

Indexed as

actinide separationsactinium-225nitrate saltsselective precipitationthorium

Identifiers

PMID42357540
PMCPMC13305970

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.